Adaptive Biotechnologies Corp ADPT:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 04/17/24 EDT
2.44quote price arrow down-0.31 (-11.27%)
Volume
3,293,529
52 week range
2.43 - 9.08
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.44
  • 52 Week High9.08
  • 52 Week High Date06/14/23
  • 52 Week Low2.43
  • 52 Week Low Date04/17/24

Key Stats

  • Market Cap354.025M
  • Shares Out145.09M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-50.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.44
  • 52 Week High9.08
  • 52 Week High Date06/14/23
  • 52 Week Low2.43
  • 52 Week Low Date04/17/24
  • Market Cap354.025M
  • Shares Out145.09M
  • 10 Day Average Volume2.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-50.2

RATIOS/PROFITABILITY

  • EPS (TTM)-1.56
  • P/E (TTM)-1.56
  • Fwd P/E (NTM)-1.88
  • EBITDA (TTM)-179.375M
  • ROE (TTM)-58.31%
  • Revenue (TTM)170.276M
  • Gross Margin (TTM)55.63%
  • Net Margin (TTM)-132.32%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adaptive Biotechnologies Corp

 

Profile

MORE
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its proprietary technologies to read the diverse genetic code of a patient’s immune system and understand precisely how the immune system detects and treats disease in that patient. It has business around two main areas:...
Chad Robins
Chairman of the Board, Chief Executive Officer, Co-Founder
Julie Rubinstein
President, Chief Operating Officer
Kyle Piskel
Chief Financial Officer
Address
1165 Eastlake Ave E
Seattle, WA
98109
United States

Top Peers

SYMBOLLASTCHG%CHG
CDMO
Avid Bioservices Inc
6.71-0.54-7.45%
AKBA
Akebia Therapeutics Inc
1.39-0.01-0.71%
TRDA
Entrada Therapeutics Inc
12.22-0.50-3.93%
HRTX
Heron Therapeutics Inc
2.77-0.16-5.46%
XERS
Xeris Biopharma Holdings Inc
1.78-0.02-1.11%